Einzeltreffer — DigiBib

Objective: To know the epidemiological behavior and associations of AF in Mexican population.

Material and Methods: 8,686 patients from 38 cardiologists participating in REMECAR were analyzed. They were divided by gender and age, the comorbidities studied were obesity, chronic kidney disease (CKD), high blood pressure (HBP), diabetes mellitus (DM), dyslipidemia,stroke, chronic obstructive pulmonary disease (COPD), hypothyroidism, heart failure (HF) and ischemicheart disease (IHD). Program used: IBM SPSS Statistic.

Results: AF was diagnosed in 498 patients (5.7%), with higher prevalence in men (6.1% vs. 5.3%) and older age in women (74.3 ± 12.1 vs. 70.5 + -12.3 years, p<0.0001). In those under 60 years, AF was associated in women with HF, in men with CKD, DM, stroke, hypothyroidism and HF. In women older than 60 years, AF was associated with CKD, dyslipidemia, stroke, chronic COPD and HF, in men with CKD, stroke, COPD, hypothyroidism, HF and IHD. AF in women increase the probability 1.13 for obesity, 1.13 for HBP, 2.8 for CKD, 2.9 for COPD, 4.3 for stroke and 6.5 for HF, in men increase the probability 1.05 for HBP, 1.4 for DM, 2.1 for CKD, 2.4 for COPD, 3.0 for hypothyroidism, 4.7 for stroke and 6.0 for HF.

Conclusions: AF is a very common arrhythmia, with a higher prevalence in patients attending the cardiology consultation, in men and with an older age of presentation in women. The older the age, the higher the prevalence of AF and comorbidities, HF is the most frequent condition associated with AF.

Titel:	Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women
Autor/in / Beteiligte Person:	Rodríguez-Reyes, H ; Laguna-Muñoz, CI ; Gallegos-de Luna, CF ; MO, de-Los-Ríos-Ibarra ; Salas-Pacheco, JL ; Leyva-Pons, JL ; Muñoz-Gutiérrez, LM ; Vargas-Hernandez, A ; Rodríguez-Muñoz, KM ; Barragán-Luna, J ; Alcocer-Gamba, MA ; Cortez-Lawrenz, J ; Farjat-Ruiz, J
Link:	Full Text Finder (Volltext)
Zeitschrift:	Archivos de cardiologia de Mexico, Jg. 92 (2022-07-01), Heft 3, S. 349-357
Veröffentlichung:	2019- : [Mexico, D.F.] : Permanyer Mexico ; <i>Original Publication</i>: México, D.F. : Instituto Nacional de Cardiología Ignacio Chávez, 2001-, 2022
Medientyp:	academicJournal
ISSN:	1665-1731 (electronic)
DOI:	10.24875/ACM.21000120
Schlagwort:	Female Humans Male Obesity complications Obesity epidemiology Risk Factors Atrial Fibrillation complications Atrial Fibrillation diagnosis Atrial Fibrillation epidemiology Diabetes Mellitus epidemiology Heart Failure diagnosis Hypertension complications Hypertension epidemiology Hypothyroidism complications Hypothyroidism epidemiology Pulmonary Disease, Chronic Obstructive complications Pulmonary Disease, Chronic Obstructive epidemiology Renal Insufficiency, Chronic epidemiology Stroke epidemiology
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: Spanish; Castilian Transliterated Title: Fibrilación auricular en población mexicana: Diferencias en presentación, comorbilidades y factores de riesgo entre hombres y mujeres Publication Type: Journal Article Language: Spanish; Castilian [Arch Cardiol Mex] 2022 Jul 01; Vol. 92 (3), pp. 349-357. <i>Date of Electronic Publication: </i>2022 Jul 01. MeSH Terms: Atrial Fibrillation* / complications ; Atrial Fibrillation* / diagnosis ; Atrial Fibrillation* / epidemiology ; Diabetes Mellitus* / epidemiology ; Heart Failure* / diagnosis ; Hypertension* / complications ; Hypertension* / epidemiology ; Hypothyroidism* / complications ; Hypothyroidism* / epidemiology ; Pulmonary Disease, Chronic Obstructive* / complications ; Pulmonary Disease, Chronic Obstructive* / epidemiology ; Renal Insufficiency, Chronic* / epidemiology ; Stroke* / epidemiology ; Female ; Humans ; Male ; Obesity / complications ; Obesity / epidemiology ; Risk Factors References: J Am Heart Assoc. 2014 Oct 07;3(5):e001211. (PMID: 25292185) ; Clin Geriatr Med. 2016 May;32(2):315-29. (PMID: 27113149) ; Gac Med Mex. 2014 Dec;150 Suppl 1:48-59. (PMID: 25643677) ; JACC Heart Fail. 2017 Aug;5(8):552-560. (PMID: 28624486) ; Am J Cardiol. 2019 Nov 1;124(9):1406-1412. (PMID: 31474328) ; J Am Coll Cardiol. 2019 Aug 27;74(8):1107-1115. (PMID: 31439220) ; Circ Res. 2018 Jan 19;122(2):352-368. (PMID: 29348255) ; Am Heart J. 2014 Jan;167(1):123-6. (PMID: 24332151) ; Rev Esp Cardiol (Engl Ed). 2015 Aug;68(8):691-9. (PMID: 25697076) ; Lancet. 2015 Jul 11;386(9989):154-62. (PMID: 25960110) ; J Cardiol. 2017 May;69(5):699-705. (PMID: 28188041) ; JACC Clin Electrophysiol. 2015 Jun;1(3):164-173. (PMID: 29759360) ; Circulation. 2020 Apr 21;141(16):e750-e772. (PMID: 32148086) ; J Am Coll Cardiol. 2016 Sep 27;68(13):1452-1464. (PMID: 27659468) ; Circulation. 2019 Feb 19;139(8):1025-1035. (PMID: 30779652) ; Eur J Prev Cardiol. 2016 Apr;23(6):621-7. (PMID: 26254188) ; Eur Heart J. 2020 Jan 1;41(1):111-188. (PMID: 31504418) ; Front Physiol. 2019 Feb 26;10:135. (PMID: 30863315) ; J Am Heart Assoc. 2020 Oct 20;9(19):e016810. (PMID: 32924719) ; Europace. 2015 Jan;17(1):24-31. (PMID: 24957921) ; Europace. 2017 Sep 1;19(9):1413-1415. (PMID: 28407056) ; Cureus. 2019 Apr 16;11(4):e4483. (PMID: 31249760) ; Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31. (PMID: 31862745) ; Eur Heart J. 2018 Nov 21;39(44):3958-3960. (PMID: 30329031) ; Nat Rev Cardiol. 2016 Mar;13(3):131-47. (PMID: 26658575) ; Stroke. 2016 Mar;47(3):895-900. (PMID: 26786114) ; BMJ. 2016 Sep 06;354:i4482. (PMID: 27599725) ; Drugs Aging. 2019 Apr;36(4):321-340. (PMID: 30613912) ; Hypertension. 2017 Nov;70(5):854-861. (PMID: 28893897) ; Circulation. 2018 Oct 23;138(17):e484-e594. (PMID: 30354654) ; Sci Rep. 2017 Oct 5;7(1):12716. (PMID: 28983076) ; J Am Coll Cardiol. 2017 Oct 17;70(16):2022-2035. (PMID: 29025560) ; Europace. 2016 May;18(5):665-71. (PMID: 26504109) ; Eur Heart J. 2016 Oct 7;37(38):2893-2962. (PMID: 27567408) ; JACC Heart Fail. 2019 Jun;7(6):447-456. (PMID: 31146871) ; Int J Cardiol. 2015 Apr 1;184:617-622. (PMID: 25770841) ; Salud Publica Mex. 2018 May-Jun;60(3):224-232. (PMID: 29746739) ; J Am Med Dir Assoc. 2019 Feb;20(2):123-130. (PMID: 30270028) ; J Cardiovasc Med (Hagerstown). 2015 Dec;16(12):795-801. (PMID: 25806470) ; Circ Res. 2017 Apr 28;120(9):1501-1517. (PMID: 28450367) ; Nat Med. 2019 Nov;25(11):1657-1666. (PMID: 31700185) ; Circ Cardiovasc Interv. 2019 Jun;12(6):e007661. (PMID: 31167601) ; Circulation. 2017 Aug 8;136(6):e137-e161. (PMID: 28455343) ; Salud Publica Mex. 2019 Nov-Dic;61(6):888-897. (PMID: 31869552) ; Expert Rev Cardiovasc Ther. 2019 Mar;17(3):209-223. (PMID: 30757925) ; Nat Rev Cardiol. 2016 Jun;13(6):321-32. (PMID: 27053455) ; Arch Bronconeumol (Engl Ed). 2020 Feb;56(2):65-67. (PMID: 31320191) ; Methodist Debakey Cardiovasc J. 2015 Oct-Dec;11(4):228-34. (PMID: 27057292) ; J Am Coll Cardiol. 2017 Apr 18;69(15):1968-1982. (PMID: 28408027) ; Lancet Neurol. 2015 Apr;14(4):377-87. (PMID: 25748102) Contributed Indexing: Keywords: Atrial fibrillation; Epidemiology; Comorbidity; Risk factors; Mexican population ; Local Abstract: [Publisher, Spanish; Castilian] Conocer el comportamiento epidemiológico y asociaciones de la FA en población mexicana. [Publisher, Spanish; Castilian] Analizamos 8,686 pacientes de 38 cardiólogos inscritos en REMECAR, divididos por edad y sexo. Comorbilidades estudiadas: obesidad, ERC, HTA, DM, dislipidemia, EVC, EPOC, hipotiroidismo, IC y CI. Programa: IBM SPSS. [Publisher, Spanish; Castilian] FA en 498 pacientes (5.7%), mayor prevalencia en hombres (6.1 vs. 5.3%), mayor edad en mujeres (74.3 ± 12.1 vs. 70.5 ± 12.3 años,p < 0.0001). En mujeres menores de 60 años la FA se asoció con IC (p = 0.041), en hombres con ERC (p = 0.43), DM(p = 0.009), EVC (p = 0.001), hipotiroidismo (p = 0.001) e IC (p = 0.001). En mujeres mayores de 60 años se asoció conERC (p = 0.001), dislipidemia (p = 0.001), EVC (p = 0.001), EPOC (p = 0.001) e IC (p = 0.001), en hombres con ERC(p = 0.002), EVC (p = 0.001), EPOC (p = 0.002), hipotiroidismo (p = 0.002), IC (p = 0.001) y CI (p = 0.033). En mujeres la FA se asoció con 1.13 veces mayor probabilidad de obesidad, 1.13 de HTA, 2.8 de ERC, 2.9 de EPOC, 4.3de EVC y 6.5de IC, en hombres la FA se asoció con 1.05 veces mas probabilidad de HTA, 1.4 de DM, 2.1 de ERC, 2.4 de EPOC, 3 dehipotiroidismo, 4.7 de EVC y 6 de IC. [Publisher, Spanish; Castilian] La FA es una arritmia muy frecuente, con mayor prevalencia en pacientes que acuden a consulta de cardiología, en hombres y mayor edad de presentación en las mujeres. A mayor edad, mayor prevalencia de FA y de comorbilidades, la IC es la condición más frecuente con la que se asoció la FA. Entry Date(s): Date Created: 20211110 Date Completed: 20220704 Latest Revision: 20220722 Update Code: 20240513 PubMed Central ID: PMC9262294

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Atrial fibrillation in Mexican population: Differences in presentation, comorbidities and risk factors between men and women